Filing Details
- Accession Number:
- 0000885590-12-000032
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-21 13:00:00
- Reporting Period:
- 2012-05-18
- Filing Date:
- 2012-05-21
- Accepted Time:
- 2012-05-21 17:05:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1190966 | E Laurence Paul | Montreal A8 H4R 2P9 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Acquisiton | 2012-05-18 | 5,000 | $47.00 | 42,397 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This number represents common shares purchased by the director, as well as other outstanding equity awards that were previously reported in Table 1.
Billionaire Hedge Funds
